These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 14715398)

  • 1. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain.
    Cui M; Khanijou S; Rubino J; Aoki KR
    Pain; 2004 Jan; 107(1-2):125-33. PubMed ID: 14715398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of substance P in the antinociceptive effect of botulinum toxin type A: Evidence from knockout mice.
    Matak I; Tékus V; Bölcskei K; Lacković Z; Helyes Z
    Neuroscience; 2017 Sep; 358():137-145. PubMed ID: 28673722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of botulinum toxin A on mechanical and cold allodynia in a rat model of neuropathic pain.
    Park HJ; Lee Y; Lee J; Park C; Moon DE
    Can J Anaesth; 2006 May; 53(5):470-7. PubMed ID: 16636031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of coadministration of cannabinoids and morphine on nociceptive behaviour, brain monoamines and HPA axis activity in a rat model of persistent pain.
    Finn DP; Beckett SR; Roe CH; Madjd A; Fone KC; Kendall DA; Marsden CA; Chapman V
    Eur J Neurosci; 2004 Feb; 19(3):678-86. PubMed ID: 14984418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinal botulinum neurotoxin B: effects on afferent transmitter release and nociceptive processing.
    Huang PP; Khan I; Suhail MS; Malkmus S; Yaksh TL
    PLoS One; 2011 Apr; 6(4):e19126. PubMed ID: 21559464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different antinociceptive effects of botulinum toxin type A in inflammatory and peripheral polyneuropathic rat models.
    Favre-Guilmard C; Auguet M; Chabrier PE
    Eur J Pharmacol; 2009 Sep; 617(1-3):48-53. PubMed ID: 19576881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic interaction between intrathecal ginsenosides and morphine on formalin-induced nociception in rats.
    Yoon MH; Kim KS; Lee HG; Kim CM; Kim WM; Choi JI; Kim YO
    J Pain; 2011 Jul; 12(7):774-81. PubMed ID: 21459679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation of pro- and anti-nociceptive interleukins in botulinum toxin A-induced analgesia in a rat model of neuropathic pain.
    Zychowska M; Rojewska E; Makuch W; Luvisetto S; Pavone F; Marinelli S; Przewlocka B; Mika J
    Eur J Pharmacol; 2016 Nov; 791():377-388. PubMed ID: 27619001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociceptive Effects of Botulinum Toxin Type A on Trigeminal Neuropathic Pain.
    Yang KY; Kim MJ; Ju JS; Park SK; Lee CG; Kim ST; Bae YC; Ahn DK
    J Dent Res; 2016 Sep; 95(10):1183-90. PubMed ID: 27418174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type A selectivity for certain types of pain is associated with capsaicin-sensitive neurons.
    Matak I; Rossetto O; Lacković Z
    Pain; 2014 Aug; 155(8):1516-1526. PubMed ID: 24793910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of central versus peripheral opioid system in antinociceptive and anti-inflammatory effect of botulinum toxin type A in trigeminal region.
    Drinovac Vlah V; Filipović B; Bach-Rojecky L; Lacković Z
    Eur J Pain; 2018 Mar; 22(3):583-591. PubMed ID: 29134730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamate-evoked release of adenosine and regulation of peripheral nociception.
    Aumeerally N; Allen G; Sawynok J
    Neuroscience; 2004; 127(1):1-11. PubMed ID: 15219663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for antinociceptive activity of botulinum toxin type A in pain management.
    Aoki KR
    Headache; 2003; 43 Suppl 1():S9-15. PubMed ID: 12887389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum neurotoxins and formalin-induced pain: central vs. peripheral effects in mice.
    Luvisetto S; Marinelli S; Lucchetti F; Marchi F; Cobianchi S; Rossetto O; Montecucco C; Pavone F
    Brain Res; 2006 Apr; 1082(1):124-31. PubMed ID: 16524562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type a injections for cervical and shoulder girdle myofascial pain using an enriched protocol design.
    Nicol AL; Wu II; Ferrante FM
    Anesth Analg; 2014 Jun; 118(6):1326-35. PubMed ID: 24842179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal administration of botulinum neurotoxin type A attenuates formalin-induced nociceptive responses in mice.
    Lee WH; Shin TJ; Kim HJ; Lee JK; Suh HW; Lee SC; Seo K
    Anesth Analg; 2011 Jan; 112(1):228-35. PubMed ID: 21081780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin type a antinociceptive activity in trigeminal regions involves central transcytosis.
    Nemanić D; Mustapić M; Matak I; Bach-Rojecky L
    Eur J Pharmacol; 2024 Jan; 963():176279. PubMed ID: 38123005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of nociceptive responses and spinal releases of nitric oxide metabolites and glutamate evoked by different concentrations of formalin in rats.
    Okuda K; Sakurada C; Takahashi M; Yamada T; Sakurada T
    Pain; 2001 May; 92(1-2):107-15. PubMed ID: 11323132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between nociceptor activity, peripheral edema, spinal microglial activation and long-term hyperalgesia induced by formalin.
    Fu KY; Light AR; Maixner W
    Neuroscience; 2000; 101(4):1127-35. PubMed ID: 11113361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum neurotoxin type A counteracts neuropathic pain and facilitates functional recovery after peripheral nerve injury in animal models.
    Marinelli S; Luvisetto S; Cobianchi S; Makuch W; Obara I; Mezzaroma E; Caruso M; Straface E; Przewlocka B; Pavone F
    Neuroscience; 2010 Nov; 171(1):316-28. PubMed ID: 20826198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.